Home›Search›Expert Review of Anticancer Therapy

Expert Review of Anticancer Therapy

Taylor and Francis Ltd. · United Kingdom · Est. 1962

ISSN1473-7140eISSN1744-8328

SJR Q2✓ WOS SCIE✓ Scopus / SJR

/ 100

Medium Risk

Score Breakdown

✓ WoS SCIE/SSCI+25

✓ Scopus Q2+18

Total43

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.926

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.676

Total Works

3,732

Total Citations

73,328

2yr Mean Citedness

2.24

Free JIF alternative

Retractions

Source: Retraction Watch

Aims & Scope✦ Inferred from recent articles

This journal focuses on the clinical application and management of anticancer therapies, including antibody-drug conjugates, immunotherapy, targeted therapies, and chemotherapy. It covers aspects such as toxicity management, treatment strategies for specific cancers like breast, lung, and bladder cancer, and the use of artificial intelligence and pharmacoeconomics in oncology.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 50% in field

General Information

Country / RegionUnited Kingdom

Primary LanguageEnglish

1st Year Published1962

Annual Volume~ 140 articles / year

StatusActive (last: 2026)

Total Publications3,732

Publisher OrgTaylor & Francis

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Taylor and Francis Ltd.

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

1473-7140 / 1744-8328

✅

Indexed in a trusted database?

WoS, Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

OncologyQ2

Pharmacology (medical)Q2

Subject Classification

Web of Science Categories

Oncology

Scopus Categories

Pharmacology (medical)Oncology

Research Topics (OpenAlex)

Lung Cancer Treatments and MutationsCancer Immunotherapy and BiomarkersBladder and Urothelial Cancer TreatmentsRenal cell carcinoma treatmentCancer Genomics and DiagnosticsProstate Cancer Treatment and ResearchLung Cancer Research StudiesHER2/EGFR in Cancer ResearchColorectal Cancer Treatments and StudiesLymphoma Diagnosis and Treatment